CARLSBAD, Calif., June 2 /PRNewswire-FirstCall/ -- Alphatec Holdings, Inc. (NASDAQ:ATEC), today announced the initial public offering of 9,300,000 million shares of common stock at a price of $9.00 per share. Alphatec has also granted the underwriters an option to purchase up to an additional 1,395,000 shares of common stock at the initial public offering price to cover over-allotments, if any. The common stock will trade on the NASDAQ National Market under the symbol "ATEC." Net proceeds from the offering are expected to be approximately $71.4 million, or $83.1 million if the underwriters exercise their over-allotment option in full, after deducting the underwriting discounts and commissions and the estimated offering expenses. Alphatec expects to use approximately $35.7 million of the net proceeds from the offering to expand its sales and marketing activities, to support its research and development efforts, to fund the clearance or approval and subsequent commercialization of its near-term product candidates, to acquire complementary businesses, products, or technologies, or to obtain the right to use such complementary technologies, to pay down debt; and for general corporate purposes. The remaining net proceeds from the offering will be used to satisfy redemption and dividend obligations to Alphatec's existing stockholders. Deutsche Bank Securities and First Albany Capital acted as joint book-running managers and RBC Capital Markets acted as co-manager for the offering. A registration statement relating to these securities has been filed with, and declared effective by, the Securities and Exchange Commission. This announcement shall not constitute an offer to sell or the solicitation of an offer to buy the common stock of Alphatec, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Copies of the final prospectus may be obtained by contacting Deutsche Bank Securities Inc., c/o Prospectus Department, 60 Wall Street, Floor 2, New York, New York 10005. About Alphatec Holdings, Inc. Alphatec Holdings, Inc. is a medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders. Alphatec's principal product offering is primarily focused on the U.S. spine fusion market through its wholly-owned subsidiary, Alphatec Spine, Inc., and includes a variety of spinal implant products and systems comprised of components such as spine screws, spinal spacers, and plates that offer multiple solutions to address patients' needs. In addition to Alphatec's U.S. presence, it also participates in the Japanese spine fusion and orthopedic trauma markets through its subsidiary, Alphatec Pacific, Inc. INVESTOR CONTACT: Matthew Clawson, Allen & Caron, Inc. (949) 474-4300, Web site: http://www.alphatecspine.com DATASOURCE: Alphatec Holdings, Inc. CONTACT: Investors, Matthew Clawson of Allen & Caron, Inc., +1-949-474-4300, , for Alphatec Holdings, Inc. Web site: http://www.alphatecspine.com/

Copyright